Back to results
US 2015/0307604 A1Published application
Antibody therapy for use in the digestive tract
AssigneeAvaxia Biologics, Incorporated
InventorBarbara S. Fox
Life of this patent
Estimating the term…
Abstract
In accordance with the invention, the development and use of antibodies within the digestive tract is provided. Antibodies are described that are used to treat disorders associated with altered permeability of the digestive tract. Antibodies are described with increased stability within the environment of the digestive tract. Antibodies are described with enhanced permeability to a compromised digestive tract.
Claims6
A stabilized antibody for topical administration to the digestive tract.
Dependencies are inferred from the claim text.